OtherVC-backedIPO 2024
Chicago, United States · Founded 2015
Tempus AI
AI-enabled precision medicine.
About Tempus AI
Clinical and molecular data platform that helps oncologists tailor cancer treatment to each patient. Public via 2024 IPO.
Company facts
- Category
- Other
- Funding stage
- IPO 2024
- Total raised
- Public (NASDAQ: TEM)
- Founded
- 2015
- Team size
- 1001+
- HQ
- Chicago
- Country
- United States
- Website
- tempus.com
Founders of Tempus AI
- Eric Lefkofsky
Investors backing Tempus AI
- Baillie Gifford
- T. Rowe Price
Frequently asked questions
What does Tempus AI do?
Clinical and molecular data platform that helps oncologists tailor cancer treatment to each patient. Public via 2024 IPO.
Where is Tempus AI based?
Tempus AI is based in Chicago, United States.
When was Tempus AI founded?
Tempus AI was founded in 2015.
How much has Tempus AI raised?
Tempus AI has raised Public (NASDAQ: TEM) in their IPO 2024 round.
Who founded Tempus AI?
Tempus AI was founded by Eric Lefkofsky.
Who has invested in Tempus AI?
Tempus AI is backed by Baillie Gifford, T. Rowe Price.